Bureau Expands Device Intelligence with Next-Gen Capabilities to Detect Coordinated Fraud
Built on two years of frontline fraud prevention, now reengineered as next-gen…
Aon’s 2025 Global Cyber Risk Report Reveals Reputation Risk Events Can Reduce Shareholder Value by 27 percent
DUBLIN, June 17, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global…
XRP price: Massive sell-off forces holders to flock to EarnMining for stable income
Houston, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- After experiencing a short-term…
MEXC Unveils “Proof of Trust” Campaign for Crypto Security, Audits, and User Protection
VICTORIA, Seychelles, June 16, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=420&resize=420,280&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
After a thorough clinical review, the benefit-risk for the use of Elevidys…
Zero Trust Security Reduces Cyber Insurance Claims, Preventing up to $465 Billion Annually in Global Economic Loss from Cyber Attacks
Nearly a third of the cyber events encompassed by the study potentially…
SEON Launches AI-Powered Anti-Money Laundering Suite, Enhancing its Comprehensive Command Center for Risk Management
AUSTIN, Texas, June 10, 2025 (GLOBE NEWSWIRE) -- SEON, a global leader…
Ned Introduces Spotlight, a Lightweight Solution for Instant Cash Flow Insight
Spotlight delivers real-time cash flow visibility so lenders can reduce risk, cut…
Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
46% reduction in the risk of disease progression or death, and 27%…
Aon appoints Andy Marcell to serve as CEO of Global Solutions
DUBLIN, June 2, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global…